4//SEC Filing
Hanna John Walter JR 4
Accession 0001781127-26-000002
CIK 0001217234other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:58 PM ET
Size
7.0 KB
Accession
0001781127-26-000002
Research Summary
AI-generated summary of this filing
CareDx (CDNA) CEO John W. Hanna Jr. Sells 19,480 Shares
What Happened
- John W. Hanna Jr., President, CEO and a director of CareDx (CDNA), sold a total of 19,480 shares in open-market transactions. He disposed of 200 shares on 2026-01-21 at $21.00 ($4,200) and 19,280 shares on 2026-01-22 at a weighted average price of $21.16 (≈ $408,023). Combined proceeds were about $412,223. These were sales (S), which are typically routine dispositions rather than purchases indicating new insider conviction.
Key Details
- Transaction dates and prices:
- 2026-01-21: 200 shares sold at $21.00 (total $4,200).
- 2026-01-22: 19,280 shares sold at a weighted average price of $21.16 (≈ $408,023); reported price range for these trades was $21.00–$21.43 per share.
- Total shares sold: 19,480; total proceeds ≈ $412,223.
- Shares owned after transaction: Not specified in the summary provided here — see the Form 4 for updated holdings.
- Notable footnotes:
- The 2026 sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2024 (prearranged plan).
- The weighted average price reflects multiple trades; the filer can provide a breakdown of shares sold at each price on request.
- Filing timeliness: Form 4 was filed on 2026-01-23 for transactions on 2026-01-21 and 2026-01-22; no late filing is indicated.
Context
- These sales were executed under a pre-established 10b5-1 plan, which generally allows insiders to sell according to a predetermined schedule and reduces the likelihood that the trades reflect immediate insider views on company prospects. Sales do not necessarily signal negative information about the company; purchases are typically more informative about insider sentiment.
Insider Transaction Report
Form 4
CareDx, Inc.CDNA
Hanna John Walter JR
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1]2026-01-21$21.00/sh−200$4,200→ 616,685 total - Sale
Common Stock
[F1][F2]2026-01-22$21.16/sh−19,280$408,023→ 597,405 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ John Walter Hanna, Jr.|2026-01-23
Documents
Issuer
CareDx, Inc.
CIK 0001217234
Entity typeother
Related Parties
1- filerCIK 0001781127
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:58 PM ET
- Size
- 7.0 KB